US FDA slaps Aurobindo Pharma#39;s Telengana injectable facility with 7 observations

Estimated read time 1 min read

The company said that these observations are procedural in nature and will be responded to within the stipulated time.

You May Also Like

More From Author

+ There are no comments

Add yours

Comments are closed.